Rose Geoffrey Beran's Form 4 filing
Pulmonx Corp (LUNG) · filed Jun 4, 2025
- Accession no.
- 0001415889-25-015643
- Filed
- Jun 4, 2025
- Trade date
- Jun 2, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $21.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rose Geoffrey BeranCIK 0001804146 | Officer (CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2025 | Common Stock | SSaleDisposed | −401 | $3.14 | −$1,259.14 | 392,877 | Direct | |
| Jun 2, 2025 | Common Stock | SSaleDisposed | −708 | $3.13 | −$2,216.04 | 392,169 | Direct | |
| Jun 2, 2025 | Common Stock | SSaleDisposed | −1,799 | $3.13 | −$5,630.87 | 390,370 | Direct | |
| Jun 2, 2025 | Common Stock | SSaleDisposed | −1,576 | $3.13 | −$4,932.88 | 388,794 | Direct | |
| Jun 2, 2025 | Common Stock | SSaleDisposed | −2,463 | $3.13 | −$7,709.19 | 386,331 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.